CD274 and neoplasm: In a subsequent trial carried out on newly diagnosed patients with metastatic gastric cancer, Nivolumab plus chemotherapy in a first-line setting showed a significant improvement of OS, as compared to chemotherapy alone in patients with PD-L1-positive tumor CPS ≥ 1.